HOME >> BIOLOGY >> NEWS
Pall prion removal technology presented to FDA blood products advisory committee

East Hills, NY (March 17, 2005) -- An update on Transmissible Spongiform Encephalopathies (TSEs), including variant Creutzfeldt-Jakob Disease (vCJD), the human form of "mad cow" disease, was a key topic at the Food & Drug Administration's Blood Products Advisory Committee meeting in Gaithersburg, Maryland today. Issues such as the number of people that could be harboring vCJD as carriers, the impact on the blood supply and new risk reduction measures were addressed. Pall Corporation (NYSE: PLL) presented an overview of the latest research on its prion reduction technology as a new risk reduction measure to help prevent transfusion transmission of infectious prions that can cause vCJD. The Company expects to launch the new filter commercially in Europe this spring.

TSEs, also called prion diseases, are fatal neurodegenerative diseases that include vCJD in humans; bovine spongiform encephalopathy (BSE) in cattle; chronic wasting disease (CWD) in deer, elk and moose; and scrapie in sheep. These diseases are believed to be caused by prions, which are misfolded, or "rogue", infectious proteins.

"So much remains unknown about prion diseases even as new information comes to light practically daily. No one really knows how many people may be harboring vCJD without clinical symptoms and could potentially transmit the infection via blood transfusion," according to Joseph Cervia, MD, a leading infectious disease expert and medical director of Pall Corporation.

He outlined the myriad questions and uncertainties surrounding vCJD and other prion diseases. These include the length of the incubation period from time of exposure to the onset of symptoms; the number of people potentially harboring vCJD who are asymptomatic; the relationship to other neurodegenerative diseases including Alzheimer's Disease; and whether other prion diseases, such as CWD found in elk and deer across the U.S., can also cross the species barrier to humans, as is the case with B
'"/>

Contact: Patricia Iannucci
piannucci@pall.com
516-801-9100
Pall Corporation
17-Mar-2005


Page: 1 2 3

Related biology news :

1. Soil particles found to boost prions capacity to infect
2. Study advances vCJD prion detection
3. Alzheimers prevention role discovered for prions
4. Scientists identify prions infectious secret
5. Vaccine prevents prion disease in mice
6. Scripps research study reveals structural dynamics of single prion molecules
7. Brown team finds crucial protein role in deadly prion spread
8. Brittle prions are more infectious
9. Soil-bound prions that cause CWD remain infectious
10. New evidence questions the simple link between prion proteins and vCJD
11. Pall blood filtration technology removes prions that can cause TSEs

Post Your Comments:
(Date:5/24/2013)... non-coding RNAs are small molecules that help control ... they have emerged as disease biomarkers. miRNA profiles ... cancers of unknown primary origin, determine prognosis, monitor ... tractable, diagnostic methods for monitoring miRNA expression in ... issue of the Journal of Clinical Investigation ...
(Date:5/24/2013)... 500 leading water scientists from around the world today ... the short span of one or two generations, the ... be living under the handicap of severe pressure on ... there is no substitute. This handicap will be self-inflicted ... bluntly pointed to chronic underlying problems led by mismanagement ...
(Date:5/23/2013)... Laboratory honored more than 165 staff for their ... PNNL,s annual Intellectual Property Commercialization Recognition & Rewards ... national laboratory named materials scientist Jun Liu Inventor ... materials that can store large amounts of energy, ... the time it takes to charge cell phones, ...
Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
(Date:5/23/2013)... (PRWEB) May 23, 2013 Graphite ... self-lubricating bushings mounted in stainless steel pillow ... properties of GRAPHALLOY with the application and installation ... Steel Pillow Blocks work exceptionally well when ... or hostile liquids such as acids, alkalies, hydrocarbons, ...
(Date:5/23/2013)... , May 23, 2013  Rahal Letterman Lanigan ... human cord blood stem cell banking and therapeutics, announced ... the No. 16 Acorn Stairlifts Indy car driven by ... the remainder of the IZOD IndyCar 2013 season.   ... will work to support awareness of umbilical cord blood ...
(Date:5/23/2013)... , May 23, 2013 VG Energy, ... alliance with DAK Renewable Research to conduct field ... yield. VG Energy is a majority owned subsidiary ... VG Energy,s exclusively licensed compound LipidMax ... oil yield in plants, possessing a wide variety ...
(Date:5/23/2013)... Pa. , May 23, 2013 ... research and advisory firms for specialized biopharmaceutical issues, ... hepatologists, and infectious disease specialists reported that in ... patients (e.g., intentionally delaying treatment) in anticipation of ... than six months ago, when only 6 percent ...
Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
Cached News: